{"id":"https://genegraph.clinicalgenome.org/r/409fc24a-1912-49b8-b2c8-85ead95b492av2.0","type":"EvidenceStrengthAssertion","dc:description":"\\PMS2 was first reported in relation to autosomal recessive constitutional mismatch repair deficiency (CMMRD) syndrome in 2000 (De Rosa et al. PMID: 10763829). Other mismatch repair (MMR) genes MLH1, MSH2 and MSH6 also cause CMMRD syndrome. CMMRD syndrome is a rare disease that greatly increases the risk of developing childhood cancer(s) such as colorectal cancers, glioblastoma, leukemia or lymphoma. Other phenotypes of CMMRD include café-au-lait spots or hypopigmentation. Note that PMS2 related cMMRD is also associated with a significant B cell-intrinsic class switch recombination defect. Three patients with MMR phenotypes have been reported with variable hypogammaglobulinemia, two of whom also have hyper-IgM syndrome  (PMID: 18824584). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in the inheritance pattern and phenotypic variability in terms of cancer spectrum and age of onset between CMMRD and Lynch syndrome. Therefore, this curation focuses on CMMRD and Lynch syndrome is curated separately. 9 variants (2 missense, 2 nonsense, and 5 frameshift) have been reported in 6 probands with biallelic variants in 5 publications (PMIDs: 10763829, 15077197, 14574005, 17557300, 18030674) are included in this curation.  IHC and western blot show absence of PMS2 protein in non-malignant patient tissues. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by animal models and in vitro functional assays (6.5 points. PMIDs: 9500552, 9927034, 11809679, 15340263, 16204034, 17557300, 18030674). Multiple PMS2 deficient mouse models have been established to show consistent phenotypes with cMMRD patients by developing lymphoma, leiomyosarcoma and myxoid liposarcoma.  In summary, there is definitive evidence to support the relationship between PMS2 and autosomal recessive CMMRD syndrome . This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/409fc24a-1912-49b8-b2c8-85ead95b492a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T22:13:22.638Z","role":"Publisher"},{"agent":"https://genegraph.clinicalgenome.org/agent/10080","role":"SecondaryContributor"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b929a6ff-89ba-41a4-832e-468976798620","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a335d8e-fb7e-4887-9682-3dd7c1b306b2","type":"Finding","dc:description":"Immunohistochemical analysis showed loss of PMS2 expression in the tumor and nonneoplastic tissue (Supplementary Fig. S1), whereas MLH1, MSH2, and MSH6 were strongly expressed.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"Immunohistochemical analysis showed loss of PMS2 expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54a3d390-37b8-4bbe-ae5f-94da3d1c38aa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07080359-8ba6-4304-8669-d4614c58a0e7","type":"Finding","dc:description":"An absence of IHC staining in both normal and tumor tissues was observed. In western blot analysis, the PMS2 protein was nearly absent from the lymphocytes of the two sisters, compared to control lymphocytes (Fig. 2B).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"IHC and western blot show absence of PMS2 protein","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9d411d6b-3ba4-480c-9e32-fcfedaf0f77d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77b7394f-a1a4-4a4a-922a-b3385f7a6c09","type":"Finding","dc:description":"Mismatch bound MutSa (or MutSb) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. MLH1 also causes constitutional mismatch repair deficiency syndrome","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9927034","rdfs:label":"MLH1 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7354aaf6-2816-40ba-a25f-e3815a7fcfef","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69ea5c62-fce6-4e3d-9079-df129b96187c","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. MSH6 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15340263","rdfs:label":"MSH6 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1c74b0ee-d19f-4a74-992c-dc458f94e2c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c381787-27ff-4a99-ba1c-cdc3391af21b","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. MSH2 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","rdfs:label":"MSH2 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f1e7480-5dc2-4718-b032-f86b86497de8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5653748d-cc39-4828-baf4-46f285d4d8de","type":"Finding","dc:description":"Pms2 -/- mice develops lymphoma, leiomyosarcoma and myxoid liposarcoma.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9500552","rdfs:label":"Tumour susceptibility in Pms2 deficient mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a12152f6-2c83-4e43-a66c-71dbd1ae859f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6a1b2c6-4d46-498b-96f9-00b14282f6ef","type":"Finding","dc:description":"Pms2 -/- mice develops lymphomas. Mlh3 \u0001-/-\u0001 ; Pms2\u0001-/\u0001- mice show gastrointestinal tumor.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16204034","rdfs:label":"Pms2 -/- mice develops lymphomas.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38bc9d1d-a436-4f21-9952-bd5e7790a797_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d86fc49e-0eb3-4731-8091-20cd2f1595e1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","rdfs:label":"Hamilton et al. 1995","family":{"id":"https://genegraph.clinicalgenome.org/r/d86fc49e-0eb3-4731-8091-20cd2f1595e1","type":"Family","rdfs:label":"Hamilton et al. 1995","member":{"id":"https://genegraph.clinicalgenome.org/r/320bf2b7-d953-44b9-8ec6-4ac8b834fa13","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","rdfs:label":"an 18-year-old man","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5f1642f7-f861-466f-951e-d92eeb546222","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2186_2187del (p.Leu729GlnfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA011018"}},{"id":"https://genegraph.clinicalgenome.org/r/dd31068d-5c35-452c-b541-752311ce3091","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.400C>T (p.Arg134Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9234"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003003","obo:HP_0100843","obo:HP_0000957","obo:HP_0012539"],"previousTesting":true,"previousTestingDescription":"Hamilton et al. 1995","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1683b34f-9a03-4d34-bafe-cf2da2e7438a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f1642f7-f861-466f-951e-d92eeb546222"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/d7b7acc2-dc7e-4daa-8fd1-1f142c346e49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd31068d-5c35-452c-b541-752311ce3091"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0012539","obo:HP_0100843","obo:HP_0003003","obo:HP_0000957"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/320bf2b7-d953-44b9-8ec6-4ac8b834fa13"}},{"id":"https://genegraph.clinicalgenome.org/r/695c8285-8a73-474f-8b66-411856c59882_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","rdfs:label":"a Turcot family","estimatedLodScore":1.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/695c8285-8a73-474f-8b66-411856c59882","type":"Family","rdfs:label":"a Turcot family","member":{"id":"https://genegraph.clinicalgenome.org/r/c42d85c4-43ef-450e-8f7b-dea321c8ff6d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","rdfs:label":"III-2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/47e7e0ca-6d6c-4b86-b709-70a91786371d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2361_2364del (p.Phe788CysfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/91338"}},{"id":"https://genegraph.clinicalgenome.org/r/35eb1508-212e-4025-b333-9b2a9e3c68c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.1221del (p.Thr408LeufsTer40)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9235"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0030692","obo:HP_0003006","obo:HP_0006716"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d4b3cb79-6aea-4454-b477-42176d1afbf7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","allele":{"id":"https://genegraph.clinicalgenome.org/r/35eb1508-212e-4025-b333-9b2a9e3c68c8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/6d3121a4-c748-40b0-a000-f6261a51e7ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","allele":{"id":"https://genegraph.clinicalgenome.org/r/47e7e0ca-6d6c-4b86-b709-70a91786371d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0006716","obo:HP_0003006","obo:HP_0030692"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c42d85c4-43ef-450e-8f7b-dea321c8ff6d"}},{"id":"https://genegraph.clinicalgenome.org/r/2fe9bac4-1f37-4b55-a085-7abb20b5d77f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"Family II","family":{"id":"https://genegraph.clinicalgenome.org/r/2fe9bac4-1f37-4b55-a085-7abb20b5d77f","type":"Family","rdfs:label":"Family II","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7e7290f0-b617-4a5d-9596-849565e9249e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","rdfs:label":"Patient 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/c26f6e60-824e-479d-ba55-cd40cd7b08bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.182del (p.Tyr61LeufsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/91316"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000957","obo:HP_0100843"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3b5008ba-2db2-4bac-817f-18ba22a3a3d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18030674","allele":{"id":"https://genegraph.clinicalgenome.org/r/c26f6e60-824e-479d-ba55-cd40cd7b08bb"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000957","obo:HP_0100843"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7e7290f0-b617-4a5d-9596-849565e9249e"}},{"id":"https://genegraph.clinicalgenome.org/r/44090396-f4c2-46b6-b2f8-7a80ad6a1dc0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"Family C01204","estimatedLodScore":4.23,"family":{"id":"https://genegraph.clinicalgenome.org/r/44090396-f4c2-46b6-b2f8-7a80ad6a1dc0","type":"Family","rdfs:label":"Family C01204","member":{"id":"https://genegraph.clinicalgenome.org/r/4e6dd2ff-3dca-481a-887e-7f24911274dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","rdfs:label":"Patient 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5d7d1da3-2eea-43aa-9679-083b339e863c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.137G>T (p.Ser46Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA009597"}},{"id":"https://genegraph.clinicalgenome.org/r/936f2511-2e06-42fd-a7b5-af795aac2a49","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.1731_1732delinsAGT (p.Arg578ValfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9244"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0012482","obo:HP_0100706","obo:HP_0005227","obo:HP_0040276","obo:HP_0000957"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bdb9f368-f05e-41b2-bc78-3e6372ea15b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d7d1da3-2eea-43aa-9679-083b339e863c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f487a7d9-bddb-4553-bc9a-1d2f8c22d4f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17557300","allele":{"id":"https://genegraph.clinicalgenome.org/r/936f2511-2e06-42fd-a7b5-af795aac2a49"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":29,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0100706","obo:HP_0012482","obo:HP_0040276","obo:HP_0005227","obo:HP_0000957"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/4e6dd2ff-3dca-481a-887e-7f24911274dc"}},{"id":"https://genegraph.clinicalgenome.org/r/bf55412c-ed67-4a43-860a-2ad584d118df_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14574005","rdfs:label":"Family 1","estimatedLodScore":1.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/bf55412c-ed67-4a43-860a-2ad584d118df","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f5daf839-4b4f-4768-a4db-0c469a66f0bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14574005","rdfs:label":"A sixteen-year-old Guyanese girl","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/71df6e1e-2096-4d29-a010-cf2d2edcc851","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.6(PMS2):c.1169_1170ins20 (p.?)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/91296"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001067","obo:HP_0000957","obo:HP_0003003","obo:HP_0004377"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/54b9b8e2-f815-4bff-a190-4808462f7c74_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14574005","allele":{"id":"https://genegraph.clinicalgenome.org/r/71df6e1e-2096-4d29-a010-cf2d2edcc851"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":11,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001067","obo:HP_0004377","obo:HP_0000957","obo:HP_0003003"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f5daf839-4b4f-4768-a4db-0c469a66f0bf"}},{"id":"https://genegraph.clinicalgenome.org/r/0c468c02-990a-4cc7-baba-6ebe0d8db81c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","rdfs:label":"Pedigree","estimatedLodScore":3.83,"family":{"id":"https://genegraph.clinicalgenome.org/r/0c468c02-990a-4cc7-baba-6ebe0d8db81c","type":"Family","rdfs:label":"Pedigree","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/eaf271c2-32f5-46f1-ae2d-87b0fcdb5737","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","rdfs:label":"V-2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/685f55ee-19d8-498f-bed6-0665ec854ced","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2404C>T (p.Arg802Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/9237"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0030065","obo:HP_0030692","obo:HP_0000957","obo:HP_0012539"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/15f59eff-3ce4-4a62-8efa-d8e6717a0254_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15077197","allele":{"id":"https://genegraph.clinicalgenome.org/r/685f55ee-19d8-498f-bed6-0665ec854ced"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":21,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0030065","obo:HP_0000957","obo:HP_0012539","obo:HP_0030692"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/eaf271c2-32f5-46f1-ae2d-87b0fcdb5737"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4e6dd2ff-3dca-481a-887e-7f24911274dc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e6dd2ff-3dca-481a-887e-7f24911274dc"},{"id":"https://genegraph.clinicalgenome.org/r/f487a7d9-bddb-4553-bc9a-1d2f8c22d4f8","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the PMS2 gene: S46I and a frameshift at lys577 resulting from a gene conversion event with the paralogous pseudogene PMS2CL. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f487a7d9-bddb-4553-bc9a-1d2f8c22d4f8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bdb9f368-f05e-41b2-bc78-3e6372ea15b7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb9f368-f05e-41b2-bc78-3e6372ea15b7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bdb9f368-f05e-41b2-bc78-3e6372ea15b7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Compound heterozygosity for 2 mutations in the PMS2 gene: S46I and a frameshift at lys577 resulting from a gene conversion event with the paralogous pseudogene PMS2CL. Borras et al. (2013) identified a heterozygous S46I mutation in 2 members of a Spanish family with hereditary nonpolyposis colorectal cancer-4. The substitution is located within the nucleotide binding pocket of the ATPase domain, suggesting an interference with the ATPase function. In vitro functional expression studies showed that the mutant protein had significantly reduced MMR activity (about 13%) compared to controls, confirming its pathogenicity. S46I is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/c42d85c4-43ef-450e-8f7b-dea321c8ff6d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c42d85c4-43ef-450e-8f7b-dea321c8ff6d"},{"id":"https://genegraph.clinicalgenome.org/r/6d3121a4-c748-40b0-a000-f6261a51e7ec","type":"EvidenceLine","dc:description":"A 1-bp deletion (1221delG) in exon 11 and a 4-bp deletion in exon 14 (2361delCTTC). Both mutations resulted in loss of the MLH1 interaction domain of PMS2. Both mutations are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d3121a4-c748-40b0-a000-f6261a51e7ec_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d4b3cb79-6aea-4454-b477-42176d1afbf7","type":"EvidenceLine","dc:description":"A 1-bp deletion (1221delG) in exon 11 and a 4-bp deletion in exon 14 (2361delCTTC). Both mutations resulted in loss of the MLH1 interaction domain of PMS2. Both mutations are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4b3cb79-6aea-4454-b477-42176d1afbf7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7e7290f0-b617-4a5d-9596-849565e9249e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e7290f0-b617-4a5d-9596-849565e9249e"},{"id":"https://genegraph.clinicalgenome.org/r/3b5008ba-2db2-4bac-817f-18ba22a3a3d7","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b5008ba-2db2-4bac-817f-18ba22a3a3d7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3b5008ba-2db2-4bac-817f-18ba22a3a3d7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A homozygous 1-bp deletion (182delA) in exon 3 of the PMS2 gene. Immunohistochemical analysis showed loss of PMS2 expression in the tumor and nonneoplastic tissue. It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/320bf2b7-d953-44b9-8ec6-4ac8b834fa13_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/320bf2b7-d953-44b9-8ec6-4ac8b834fa13"},{"id":"https://genegraph.clinicalgenome.org/r/1683b34f-9a03-4d34-bafe-cf2da2e7438a","type":"EvidenceLine","dc:description":"A C-to-T transition in the PMS2 gene, resulting in an arg134-to-ter (R134X) substitution and a 2-bp deletion in exon 13, within a repeated dinucleotide (CTCT) at codon 728-729. Both mutations are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1683b34f-9a03-4d34-bafe-cf2da2e7438a_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d7b7acc2-dc7e-4daa-8fd1-1f142c346e49","type":"EvidenceLine","dc:description":"A C-to-T transition in the PMS2 gene, resulting in an arg134-to-ter (R134X) substitution and a 2-bp deletion in exon 13, within a repeated dinucleotide (CTCT) at codon 728-729. Both mutations are three star variants reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7b7acc2-dc7e-4daa-8fd1-1f142c346e49_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/eaf271c2-32f5-46f1-ae2d-87b0fcdb5737_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eaf271c2-32f5-46f1-ae2d-87b0fcdb5737"},{"id":"https://genegraph.clinicalgenome.org/r/15f59eff-3ce4-4a62-8efa-d8e6717a0254","type":"EvidenceLine","dc:description":"A homozygous 2428C-to-T transition in exon 14 of the PMS2 gene, resulting in an arg802-to-ter (R802X) substitution. De Vos et al. (2006) identified homozygosity for the R802X mutation in 11 patients from 5 consanguineous families of Pakistani origin living in the UK. Further analysis of polymorphisms suggested an ancestral founder effect for the mutation.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15f59eff-3ce4-4a62-8efa-d8e6717a0254_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f5daf839-4b4f-4768-a4db-0c469a66f0bf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5daf839-4b4f-4768-a4db-0c469a66f0bf"},{"id":"https://genegraph.clinicalgenome.org/r/54b9b8e2-f815-4bff-a190-4808462f7c74","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54b9b8e2-f815-4bff-a190-4808462f7c74_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5611,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/p3SQczUCxfU","type":"GeneValidityProposition","disease":"obo:MONDO_0010159","gene":"hgnc:9122","modeOfInheritance":"obo:HP_0000007"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_38bc9d1d-a436-4f21-9952-bd5e7790a797-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}